← Back to Screener
Q/C Technologies, Inc. Common Stock (QCLS)
Price$3.72
Favorite Metrics
Price vs S&P 500 (26W)-6.15%
Price vs S&P 500 (4W)-4.07%
Market Capitalization$31.96M
All Metrics
Book Value / Share (Quarterly)$7.16
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-2.23
Price vs S&P 500 (YTD)-0.64%
Gross Margin (TTM)24.73%
Net Profit Margin (TTM)-501.52%
EPS (TTM)$-35.08
10-Day Avg Trading Volume0.31M
EPS Excl Extra (TTM)$-35.08
EPS (Annual)$-9.59
Dividend / Share (Annual)$0.50
ROI (Annual)-158.69%
Gross Margin (Annual)7.64%
Net Profit Margin (5Y Avg)-298.68%
Cash / Share (Quarterly)$3.36
ROA (Last FY)-109.05%
EBITD / Share (TTM)$-7.29
ROE (5Y Avg)-94.13%
Operating Margin (TTM)-500.57%
Cash Flow / Share (Annual)$-2.67
P/B Ratio1.50x
P/B Ratio (Quarterly)0.40x
Net Income / Employee (Annual)$-12
Net Interest Coverage (TTM)-676.08x
ROA (TTM)-32.97%
EPS Incl Extra (Annual)$-9.59
Current Ratio (Annual)1.40x
Quick Ratio (Quarterly)1.53x
3-Month Avg Trading Volume2.58M
52-Week Price Return-84.95%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$2.43
P/S Ratio (Annual)19.19x
Asset Turnover (Annual)0.21x
52-Week High$33.56
Operating Margin (5Y Avg)-298.11%
EPS Excl Extra (Annual)$-9.59
26-Week Price Return-2.16%
Quick Ratio (Annual)1.27x
13-Week Price Return-12.28%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)1.71x
Enterprise Value$25.059
Asset Turnover (TTM)0.21x
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)0.00x
Pretax Margin (Annual)-651.36%
Cash / Share (Annual)$2.53
3-Month Return Std Dev124.03%
Gross Margin (5Y Avg)45.57%
Net Income / Employee (TTM)$-4
ROE (Last FY)-158.69%
Net Interest Coverage (Annual)-1.75x
EPS Basic Excl Extra (Annual)$-9.59
Receivables Turnover (TTM)0.00x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-35.08
Receivables Turnover (Annual)0.00x
ROI (TTM)-50.73%
P/S Ratio (TTM)38.21x
Pretax Margin (5Y Avg)-301.23%
Revenue / Share (Annual)$0.00
Price vs S&P 500 (52W)-114.78%
Year-to-Date Return2.00%
5-Day Price Return14.01%
EPS Normalized (Annual)$-9.59
ROA (5Y Avg)-77.25%
Net Profit Margin (Annual)-651.36%
Month-to-Date Return17.97%
EBITD / Share (Annual)$-9.57
Operating Margin (Annual)-650.86%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-94.13%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-35.08
P/TBV (Quarterly)1.18x
P/B Ratio (Annual)0.27x
Dividend / Share (TTM)$1.22
Inventory Turnover (TTM)0.00x
Pretax Margin (TTM)-501.52%
Book Value / Share (Annual)$4.38
Price vs S&P 500 (13W)-12.97%
Dividend Yield (TTM)4.24%
Beta2.23x
Revenue / Share (TTM)$0.00
ROE (TTM)-50.73%
52-Week Low$2.50
Industry Peers — In Vitro Diagnostics(17)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
QCLSQ/C Technologies, Inc. Common Stock | 38.21x | — | 24.73% | — | $3.72 |
IDXXIdexx Laboratories Inc | 10.59x | 10.42% | 61.80% | 14.28% | $569.95 |
LNTHLantheus Holdings, Inc | 3.53x | 0.50% | 61.10% | 40.71% | $83.92 |
NNNNAnbio Biotechnology Class A Ordinary Shares | 299.06x | -5.72% | 89.00% | — | $27.80 |
CLDXCelldex Therapeutics, Inc | 1718.98x | -77.98% | 17.65% | — | $33.86 |
NEOGNeogen Corp | 2.32x | -3.91% | 45.20% | — | $9.24 |
NTLAIntellia Therapeutics, Inc | 26.08x | 16.92% | — | — | $14.16 |
QDELQuidelOrtho Corporation Common Stock | 0.31x | -1.89% | 46.67% | — | $12.69 |
MYGNMyriad Genetics Inc | 0.58x | -1.56% | 69.93% | — | $5.00 |
ACHVAchieve Life Sciences, Inc. | 14.37x | -89.25% | — | — | $4.81 |
TKNOAlpha Teknova, Inc. Common Stock | 3.62x | 7.35% | 33.17% | — | $2.68 |
About
Q/C Technologies Inc develops blockchain infrastructure using photonic computing technology to improve processing speed and energy efficiency. The company's laser-based processor architecture is designed to address computational limitations in blockchain networks while reducing power consumption. By integrating photonic computing with cryptocurrency systems, Q/C Technologies targets next-generation distributed ledger applications requiring high performance and sustainability.